Abstract
“More than two-thirds of global market value was generated by 13 major
animal health businesses in 2006. With Schering Ploughs pending acquisition of
Intervet - almost 70% of the market will be concentrated in the hands of 12
companies”
To reflect the changing nature of the industry, this edition of Animal Pharm' s
Top 20 has been restructured. It concentrates on the 12 ‘animal health
majors’ and a further 14 companies that play a significant role in the
sector to give you a broader perspective of the industry.
Key coverage
- Analyse recent merger and acquisition activity in the sector
including the impact of the pending takeover of Intervet by Schering Plough on
the market.
- Examine factors affecting market growth rates and look at the
bigger picture.
- Assess company sales rankings for 2006 and going back to 2001 as
well as forecasts for 2007data to help you prepare for.
- Review the size, structure and recent development of the global
market to aid your future planning and strategy.
- Invest in this report to keep informed of the performance of your
potential competitors, collaborators or customers.
Market data
The ultimate guide to the animal health industry and its major players is
updated and improved for 2007. With 26 company profiles included to further
enhance your competitor intelligence.
In-depth company profiles are given for the top 12 animal health companies and
a further 14 second tier companies.
Forecasts
Schering-Plough' s pending acquisition of Intervet means that by the end of
2007, almost 70% of the market will be concentrated in the hands of 12
companies. SP' s expanded animal health business will vie with Pfizer and
Merial for outright leadership of the sector, with each of these three giants
generating annual sales of more than US$2billion. The combined market share
held by the three leading players will be in excess of one-third.
Key Findings
Merger and acquisition deals have concentrated shares of the market
increasingly in the hands of a few leading players and have resulted in a
clearer split between ownership of interests in the ‘medicinal’
and ‘nutritional’ segments of the industry.
The report is tightly focused on the core animal health market - a definition
that spans veterinary pharmaceuticals, biologicals and medicinal feed
additives and excludes pure animal nutrition businesses.
Defined along those lines, the global market for animal health products was
worth almost US$18.6 billion in 2006.
Chapters
- Companies profiled included:
- Animal Health Majors:
- Alpharma, Bayer, Boehringer Ingelheim, Ceva, Elanco, Fort Dodge, Merial,
Novartis, Pfizer, Schering Plough (including Intervet), Vetoquinol, Virbac
- Other significant players:
- Central Garden & Pet, China Animal Husbandry Industry Co., Dainippon
Sumitomo Pharma, Heska, Idexx, Jansse, Kyoritsu Seiyaku, Meiji Seika Kaisha,
Monsanto, Nippon Zenyaku Kogyo, Norbrook, Orion, Phibro, Teva
Who should read this report?
Companies that are involved in the development, manufacture and sale of animal
health products either on a multi-national or local level.
View Cart
